Virus-like particle containing RNA virus nucleic acid and its preparing method and use
An RNA virus and virus-like technology, applied in the field of virus-like particles containing RNA virus nucleic acid and its preparation, can solve the problems of inaccurate detection results, loss of sample nucleic acid, unreasonable primer design, etc. Effects of stability, no risk of biological contamination
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0074] Preparation of virus-like particles containing HIV-1 viral nucleic acid 956bp in embodiment 1
[0075] The HIV nucleic acid fragments contained in the virus-like particles prepared by the present invention contain 10 fragments amplified by HIV RT-PCR kits, which are regions amplified by quantitative PCR for HIV. The present invention finds that the fragments are concentrated in HIV Genome gag region 1-956nt. Such as:
[0076] Primer 1: 5'-GGGCAAATGGTACATCAGGCCATATCAC
[0077] 3’-AGCCGAGCAAGCTTCACAGGAGGTAAAA
[0078] The amplified length is 525bp
[0079] The HIV gag plasmid used in the present invention is donated by the China Center for Disease Control and Prevention, and the gag gene on the plasmid is directly amplified from uncultivated HIV-1 positive peripheral blood. This strain is Chinese HIV E, B Subtype representative strain CN54 strain; search the sequence of this strain on MEDLINE, use the primer design software Primer 5.0 to design and ampli...
Embodiment 2
[0135] Example 2, Preparation of virus-like particles containing HIV-1 viral nucleic acid 500bp
[0136] The HIV nucleic acid fragment contained in the virus-like particle prepared by the present invention contains 5 fragments amplified by the HIV RT-PCR kit for detecting HIV, and the region amplified by quantitative PCR for HIV is HIV genome gag region 1-500nt . Other steps are with embodiment 1.
Embodiment 3
[0137] Example 3, Identification of Viral RNA Contained in Virus-Like Particles
[0138] The result of PCR reaction electrophoresis after reverse transcription and without reverse transcription of the product obtained in the embodiment is as follows: Figure 4 shown; the experimental results show that the dilution series of the reverse transcription process can amplify the target fragment; while the dilution series of direct PCR amplification without reverse transcription cannot amplify the target fragment, which proves that the nucleic acid packaged in VLPs RNA rather than DNA.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com